Sergey Jakimov

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy.

Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands.

Pantelakis Securities SA provides brokerage services. The private company is based in Athens, Greece. The Greek company was founded in 1920. The CEO is Nikos Pantelakis.

Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs.

RepRisk AG is an independent research firm headquartered in Zurich, Switzerland. The firm was founded in 1998 and provides ESG research in 20 major business languages that can be used for rigorous back-testing and quantitative analysis.

Axia Ventures Group Ltd. (Broker) (AXIA Greece) is the Greece-based securities brokerage branch of Axia Ventures Group Ltd. (ATHEX: EX) in Cyprus. Headquartered in Athens, AXIA Greece provides capital market-related services to corporates, governments and institutional clients.

Sintetica SA operates as a pharmaceutical company that provides injectable anaesthetics and analgesics. The company was founded in 1921 and is headquartered in Mendrisio, Swizerland.

CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy.

Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA.

Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland.

Inspirit IoT, Inc. delivers general-purpose High-Level Synthesis (HLS) with a focus on Machine-Learning and FPGA-based accelerators for IoT devices, cloud vendors and data centers. The company is headquartered in Champaign, IL.

Queen Mary Hospital operates general medical hospitals. The private company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Yau Fun Lau.

Bacmuno Biotechnology Ltd. provides bacteria-based immunotherapies against cancer. It applies Salmonella genetic modification technology to cancer immunotherapy in animals and humans. The company was founded on January 23, 2017 and is headquartered in Hong Kong.

Holmusk USA, Inc. develops predictive algorithms that offer insights for personalized care and population health management. It focuses on solving problems in healthcare for chronic diseases. The firm's products include AptCare Suite, which is a digital health management platform built for community chronic care, and MindLinc, which integrates mental and behavioural health and practice management at all levels. The company was founded by Nawal Roy in 2015 and is headquartered in Singapore.

Repair Biotechnologies, Inc. operates as a biotechnology company which develops clinic therapies. It specializes in developing reversing atherosclerosis and atrophy of the thymus. The company was founded by Reason Cherman and Bill Cherman in 2018 and is headquartered in Syracuse, NY.

Uni.Fund invests in start-up companies located in Greece. The fund invests in sectors such as technology services, electronic technology, health services, health technology, finance and insurance technology. It provides equity financing for pre-seed, seed and early stage capital requirements. It makes investments in pre-seed up to EUR 250,000 while EUR 250,000 - 500,000 in seed stage.

R3i Ventures Pte Ltd (R3i Ventures) is a venture capital firm founded in 2016. The firm is headquartered in Singapore.

Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.

StratifiCare is a Singaporean company that specializes in the development and manufacturing of IVD assay solutions for personalized medicine. The company is based in Singapore, SG, and has subsidiaries in the United States. With over 50 years of cumulative experience in Biomedical R&D and technology commercialization, StratifiCare is working on a new Point-of-Care Platform to transform the way patients are managed through personalized care. The company was founded in 2015 with the aim of empowering personalized medicine through innovative diagnostic solutions. Anthony Chua founded the company in 2015 and has been the CEO since then.

Deep Longevity Ltd. develops artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system and psychological levels. Its products include longevity cloud, recommendation engines, deep aging clocks and age metric reports. The company was founded in 2020 by Alex Zhavoronkov and is headquartered in San Diego, CA.

Welltech Ventures is a venture capital firm founded in 2019 by Galit Horovitz and Amir Alroy. The firm is headquartered in Tel Aviv, Israel.

Raiven Capital (Raiven Capital) is a venture capital firm founded in 2018 by Paul Dugsin and Supreet Manchanda. The firm is headquartered in Toronto, Canada.

MGA Thermal Pty Ltd. is an Australian clean energy company that specializes in energy storage. The company is based in Tomago, Australia. The company's breakthrough technology involves the use of mga blocks that store and deliver thermal energy while remaining solid. This technology is crucial for grid decarbonisation and allows renewable energy to be turned into green steam and power that is available at any time of the day. The CEO of the company is Erich Kisi.

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.

Rubens Technologies Pty Ltd. offers an intelligence system for the fresh fruit supply chain. The company is based in Knoxfield, Australia. The Australian company was founded by Leesa Soulodre, Daniel Pelliccia. Daniel Pelliccia has been the CEO since incorporation.

Cellomics International Ltd. is a Chinese biotechnology company that focuses on developing and commercializing liquid biopsy products and services. The company is based in Hong Kong, Hong Kong. Cellomics International was founded by Christine Huang and Edwin Yu, with Christine Huang serving as the CEO since incorporation.